CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0558
(Tag F0558)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview and record review, the facility failed to reasonably accommodate the needs of two of 20 sampled ...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview and record review, the facility failed to reasonably accommodate the needs of two of 20 sampled Residents (Resident 13 and 15) in accordance with the facility policy by failing to ensure:
a. Resident 13's call light (device used by a resident to signal his or her need for assistance from professional staff) was within the resident's reach
b. Resident 15's electronic (digital) clock on his bedside table personal equipment was set with the current time.
as indicated in the facility's policy.
This deficient practice had the potential to result in delay of care or services necessary for the Resident 13's wellbeing and had the potential for Resident 15 to get disoriented with time, which could affect Resident's participation with daily activities and over all wellbeing.
Findings:
a. A review of Resident 13's admission Record indicated resident was originally admitted to the facility on [DATE] and then readmitted on [DATE] with a diagnoses of hypertension (abnormally high blood pressure), hyperlipidemia (abnormally high concentration of fats or lipids in the blood), and Type 2 diabetes mellitus (a disease in which your blood glucose, or blood sugar, levels are too high).
A review of the Minimum Data Set (MDS, a standardized assessment and care screening tool), dated 10/31/22, indicated Resident 13 was severely impaired with cognitive skills for daily decision making (when a person has trouble remembering, learning new things, concentrating, or making decisions that affect their everyday life). The MDS indicated Resident 13 required extensive assistance (resident involved in activity, staff provide weight-bearing support) with bed mobility, transfer, dressing, personal hygiene and totally dependent with locomotion on and off unit and toilet use. The MDS indicated Resident 13 uses corrective lenses and was able to see large print, but not regular print in newspapers/books.
A review of Resident 13's Visual Functions care plan, dated 7/06/22, indicated staff interventions included were to place call light within reach and to answer promptly.
During an observation in Resident 13's room on 11/11/22 at 8:39 AM, Resident 13 was observed laying in bed calling out for water. Resident 13's call light was observed on the floor between Resident 13's bed and bedroom wall.
During a concurrent observation in Resident 13's room and interview with Certified Nursing Assistant 4 (CNA 4) on 11/11/22 at 8:42 AM, CNA 4 verified Resident 13's call light was on the floor. CNA 4 stated the call light should always be within resident's reach so that Resident 13 may be able to call when she needs assistance. CNA 4 stated she did not know why the call light was on the floor.
During observation in Resident 13's room on 11/12/22 at 7:28 AM, Resident 13 was observed calling out to Jesus. Resident 13's call light was observed hanging over the head of Resident 13's bed.
During a concurrent observation in Resident 13's room and interview with Licensed Vocational Nurse 3 (LVN3) on 11/12/22 at 7:29 AM, Resident 13's call light was observed hanging over the head of Resident 13's bed. LVN 3 stated the call light should always be within resident's reach to prevent an accident or injury to a resident trying to call for assistance.
During an interview with Director of Nursing (DON) on 11/13/22 at 4:38 PM, DON stated it is the facility's practice to always leave the call light within residents' reach. The DON stated it is important for all residents to have their call light within reach to get assistance from the staff when in distress to prevent accident.
A review of the facility's policy and procedure titled, Answering the Call Light, revised in May 2021, indicated when the resident is in bed or confined to a chair, be sure the call light is within easy reach of the resident.
b. A review of Resident 13's admission Record indicated Resident 15 was initially admitted to the facility on [DATE] and readmitted on [DATE] with a diagnoses that included cognitive communication deficit(an impairment in organization/ thought organization, sequencing, attention, memory, planning, problem-solving, and safety awareness), primary hypertension(a type of high blood pressure that has no clearly identifiable cause)
A review of Resident 15's History and Physical, dated 8/17/22, indicated the resident did not have capacity to understand or make decisions.
On 11/11/22 at 8:35 AM, during initial tour of the facility, an observation of an electronic clock on the bedside table next to Resident 15's bed had the time of 9:35 AM. There was a wall clock observed in Resident 15's room with the time of 8:35 AM. Resident 15 stated he had notified the nurses that his bedside clock had the wrong time, but no one fixed it. Resident 15 stated he sometimes gets confused with having two clocks with two different times in his room. Resident 15 stated he did not like not knowing what the correct time was because he relies on the time of his bedside clock for his daily activities.
On 11/12/22 at 7:20 AM, during a concurrent observation in Resident 15's room and interview with licensed vocational nurse 3 (LVN 3), LVN 3 stated Resident 15's electronic clock at bedside did not have the current time. LVN 3 stated it is everyone's (nurses, maintenance, housekeepers) responsibility to make sure everything in the resident's room is working properly. LVN 3 stated he was not aware the clock had the wrong time but would fix it.
On 11/13/22 at 7:55 AM during interview, LVN 3 stated he forgot to fix the time on Resident 15's bedside clock. LVN 3 stated he would fix Resident 15's clock right away.
On 11/13/22 at 4:30 P.M. during an interview, the Director of Nursing (DON) stated it is important for the facility to maintain the clocks in residents' room in working condition so the residents are aware of the current time and day, especially for the residents who has dementia(loss of memory, language, problem-solving and other thinking abilities that are severe enough to interfere with daily life) . The DON stated ensuring that the clocks have the right time will help the residents with reality orientation.
A review of the facility's policy and procedure titled, Homelike Environment, revised February 2021, indicated Resident are provided with a safe, clean, comfortable and homelike environment and encouraged to use their personal belongings to the extent possible
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Safe Environment
(Tag F0584)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview, observation, and record review, the facility failed to ensure personal equipment were in good repair for one...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview, observation, and record review, the facility failed to ensure personal equipment were in good repair for one of three (3) sampled residents. Resident 15's electronic (digital) clock on his bedside table was not set with the current time.
This deficient practice had the potential for Resident 15 to get disoriented with time, which could affect Resident's participation with daily activities and over all wellbeing.
Findings:
A review of Resident 13's admission Record indicated Resident 15 was initially admitted to the facility on [DATE] and readmitted on [DATE] with a diagnoses that included cognitive communication deficit(an impairment in organization/ thought organization, sequencing, attention, memory, planning, problem-solving, and safety awareness), primary hypertension(a type of high blood pressure that has no clearly identifiable cause)
A review of Resident 15's History and Physical, dated 8/17/22, indicated the resident did not have capacity to understand or make decisions.
On 11/11/22 at 8:35 AM, during initial tour of the facility, an observation of an electronic clock on the bedside table next to Resident 15's bed had the time of 9:35 AM. There was a wall clock observed in Resident 15's room with the time of 8:35 AM. Resident 15 stated he had notified the nurses that his bedside clock had the wrong time, but no one fixed it. Resident 15 stated he sometimes gets confused with having two clocks with two different times in his room. Resident 15 stated he did not like not knowing what the correct time was because he relies on the time of his bedside clock for his daily activities.
On 11/12/22 at 7:20 AM, during a concurrent observation in Resident 15's room and interview with licensed vocational nurse 3 (LVN 3), LVN 3 stated Resident 15's electronic clock at bedside did not have the current time. LVN 3 stated it is everyone's (nurses, maintenance, housekeepers) responsibility to make sure everything in the resident's room is working properly. LVN 3 stated he was not aware the clock had the wrong time but would fix it.
On 11/13/22 at 7:55 AM during interview, LVN 3 stated he forgot to fix the time on Resident 15's bedside clock. LVN 3 stated he would fix Resident 15's clock right away.
On 11/13/22 at 4:30 P.M. during an interview, the Director of Nursing (DON) stated it is important for the facility to maintain the clocks in residents' room in working condition so the residents are aware of the current time and day, especially for the residents who has dementia(loss of memory, language, problem-solving and other thinking abilities that are severe enough to interfere with daily life) . The DON stated ensuring that the clocks have the right time will help the residents with reality orientation.
A review of the facility's policy and procedure titled, Homelike Environment, revised February 2021, indicated Resident are provided with a safe, clean, comfortable and homelike environment and encouraged to use their personal belongings to the extent possible
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0657
(Tag F0657)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview and record review, the facility failed to revise and update the plan of care for two (2) of 2 sampled residen...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview and record review, the facility failed to revise and update the plan of care for two (2) of 2 sampled residents (Resident 13 and 21) for the use of psychotropic drugs (medications used to treat certain mental/mood conditions).
This deficient practice placed the resident at risk for not receiving the necessary services and treatment related to the use of Psychotropic drugs in the facility.
Findings:
1. A review of Resident 13's admission Record indicated resident was originally admitted to the facility on [DATE] and readmitted on [DATE] with diagnoses of depression (mood disorder that causes a persistent feeling of sadness and loss of interest), and Type 2 diabetes mellitus (a disease in which your blood glucose, or blood sugar, levels are too high).
A review of the Minimum Data Set (MDS, a standardized assessment and care screening tool) dated 10/31/2022 indicated Resident 13's has severely impaired cognition (when a person has trouble remembering, learning new things, concentrating, or making decisions that affect their everyday life). The MDS indicated Resident 13's indicators of psychosis (severe mental disorder that causes abnormal thinking and perception) included delusions (an unshakable belief in something untrue).
A review of Residents 13's Medication Record Report, dated 11/01/2021 until 11/30/2021, indicated an order for the following:
a. Trazadone ( medication used in the management and treatment of major depressive disorder ) 75 milligrams (mg, unit of measurement) take one (1) tablet by mouth at bedtime for depression manifested by (m/b) unable to sleep
b. Seroquel(medication is used to treat certain mental/mood conditions such as schizophrenia [mental disorder characterized by abnormal social behavior and failure to understand what is real], bipolar disorder [extreme mood swings that include mania {emotional highs} and depression which may lead to impaired functioning), 25 mg tablet (Quetiapine) give ½ tablet = 12.5 mg by mouth every evening for psychosis m/b delusion calling mama and [NAME].
A review of Resident's 13's Care Plan, dated 07/06/2022, with a goal date of 10/04/2022 indicated Resident 13 has potential for drug related complications associated with the use of psychotropic medication to manage behavior related to depression and psychosis.
2. A review of Resident 21's admission Record indicated resident was a originally admitted on [DATE] and readmitted on [DATE] with a diagnoses of major depressive disorder (mood disorder that causes a persistent feeling of sadness and loss of interest), anxiety disorder (involves persistent and excessive worry that interferes with daily activities), and dementia (loss of memory, language, problem-solving and other thinking abilities that are severe enough to interfere with daily life)
A review of the MDS, dated [DATE], indicated Resident 21's has mildly impaired cognition. The MDS indicated Resident 21's indicators of Psychosis included delusions.
A review of Residents 21's Medication Record Report, dated 11/01/2021 until 11/30/2021, indicated an order for the following:
a. Remeron (Mirtazapine, drug used to treat depression ) 15 mg 1 tablet by mouth at bedtime for depression m/b self-reporting feelings of sadness.
b. Seroquel 25 mg tablet give 1/2 tablet by mouth twice daily for psychosis m/b combativeness.
c. Ativan (Lorazepam, medicine used to treat the symptoms of anxiety disorders 1 mg tablet by mouth once daily every morning routine for anxiety m/b restlessness.
A review of Resident's 21's Care Plan, dated 07/06/2022, with a goal date of 10/04/2022, indicated Resident 21 has potential for drug related complications associated with the use of psychotropic medication to manage mood/behavior related to depression, anxiety, and impulse disorder.
On 11/12/2022 at 10:27 A.M., during a concurrent record review of Resident's 13's and 21's care plan titled, Psychotropic Drugs, and interview with the Care Plan Coordinator (CPC), the CPC stated, the care plans were created 07/06/2022 and had an update date of 10/04/2022, but they had not been updated. The CPC stated, a care plan should be revised and updated quarterly, anytime there is a change of condition, and change in a physician's order. The CPC stated it is important to have an updated and current care plan for all residents because sometimes behaviors that are being monitored could change or the approach may not be working. The CPC stated sometimes she got busy and forgets to update the care plans by the required goal/update such as for Residents 13 and 21.
On 11/13/2021 at 4: 30 P.M, during an interview with the Director of Nursing (DON), the DON stated care plans should be revised quarterly, annually, and when there is significant change. The DON stated having a current and updated care plan helps the staff to monitor Residents appropriately for adverse effects of the medication they are receiving. The DON stated it is the responsibility of the CPC or any of the licensed nurses to update the care plans. The DON stated the facility provided the care plan revision policy, however upon review of the facility policy titled, Care Plan, the policy did not include revision of care plans.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0726
(Tag F0726)
Could have caused harm · This affected 1 resident
Based on interview and record review, the facility failed to ensure the initial and annual competency (applied skills and knowledge that enable people to successfully perform at their profession) eval...
Read full inspector narrative →
Based on interview and record review, the facility failed to ensure the initial and annual competency (applied skills and knowledge that enable people to successfully perform at their profession) evaluation requirements for two (2) of five (5) Certified Nurse Assistants (CNAs) were completed as indicated on the facility policy and procedure.
1. CNA 2 was newly hired at the facility on 5/10/2022 with no documented evidence of a completed initial competency.
2. CNA 3 with no documented evidence of a completed annual competency in 2021.
This deficient practice had the potential for a knowledge and training deficit among the CNAs, which can lead to inadequate resident care.
Findings:
1. During a concurrent record review of the employee file and interview with the Director of Staff Development (DSD) on 11/13/2022 timed at 10:30 AM, the DSD stated that CNA 2 was hired on 5/10/2022. The DSD stated CNA 2 did not have an initial competency training document on file because it was missing. The DSD further stated she could not find the document checklist in CNA 2's individual folder, which would have had CNA's 2 signature acknowledging the training was done.
2. During a concurrent record review of the employee file and interview with the DSD on 11/13/2022 timed at 10:35 AM, the DSD stated CNA 3 was hired on 6/11/2013. DSD stated CNA 3 did not have a documented evidence of an annual competency completed for 2021.
During an interview with the DSD and Assistant Director of Nursing (ADON) on 11/13/2022 timed at 10:00 AM, the DSD stated a new or rehired CNA is required to go through orientation training which includes a review of the CNA's job description and work responsibilities. The DSD further stated after the CNA's orientation period, which is usually two weeks, she will assess the CNA's knowledge and skill level to determine if the CNA is ready to work on the nursing floor. The DSD stated the initial training and annual competencies are important to prevent any adverse outcome on the residents such as knowing how to prevent a a fall or develop a pressure ulcer (injury to skin and underlying tissue resulting from prolonged pressure on the skin). The DSD further stated she is responsible for overseeing the CNA's initial and annual competency. The ADON stated the DSD position was vacant from 9/2021 to 5/2022. The ADON further stated during this time, she and the DON were responsible for the CNA's new hire and annual competencies but does not recall a new hire competency being done for CNA 2 and an annual competency for CNA 3 in 2021.
A review of the facility's Policy and Procedure titled, Nurse Aid Qualifications and Training Requirements, dated 5/2019, indicated that a nursing aid must be competent to provide designated nursing care and nursing related services.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Pharmacy Services
(Tag F0755)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 8. A review of Resident 13's admission Record indicated the resident was admitted initially admitted to the facility on [DATE] a...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 8. A review of Resident 13's admission Record indicated the resident was admitted initially admitted to the facility on [DATE] and readmitted on [DATE] with a diagnosis that included hypertension (abnormally high blood pressure), hyperlipidemia (abnormally high concentration of fats or lipids in the blood), type 2 diabetes mellitus (a disease in which your blood glucose, or blood sugar, levels are too high).
A review of Resident 13's MDS, dated [DATE], indicated Resident 13's had severe impairment in cognitive skills.
A review of Resident 13's Physician's Order for November 2022 indicated the following physician orders:
a. Seroquel (Quetiapine, a drug treat schizophrenia, bipolar disorder, and depression) 25 mg tablet, give half tablet (12.5 mg) PO QPM for psychosis, manifested by delusion calling mama and [NAME], dated 11/02/22.
b. Monitor side effects antipsychotic such as: sedation, drowsiness/dizziness, dry mouth, constipation, blurred vision, extrapyramidal reaction, weight, seizures, urinary retention, tardive dyskinesia, cognitive/behavior impairment, akathisia, pseudo-Parkinsonism, orthostatic hypotension, unsteady on feet, and/or high blood sugar.
A review of Resident 13's Physician's Order: Seroquel Side Effects Summary, dated 11/1/22, indicated Resident 13 had 0 side effects from Seroquel for the month of October 2022.
A review of Resident 13's MAR for the month of November 2022, indicated Resident 13 had 0 signs and symptoms of side effects from anti-psychotic, Seroquel from 1/1/22 to 11/12/22.
A review of Resident 13's care plan for psychotropic drugs dated 7/6/22, indicated Resident 13 had the potential for drug related complications associated with the use of psychotropic medication to manage behavior related to depression and psychosis. The care plan indicated the interventions that included to observe for antidepressant side effects: such as orthostatic hypotension and tachycardia.
A review of Resident 13's Vital Stats for period 11/1/22 to 11/13/22, indicated Resident 13's vital signs such as temperature, HR, respiratory rate and BP were only taken and recorded/documented on 11/2/22, 11/4/22, and 11/7/22.
9. A review of Resident 17's admission Record indicated the resident was admitted initially to the facility on 6/17/04 and readmitted on [DATE] with a diagnosis that included depression (A mental health disorder characterized by persistently depressed mood or loss of interest in activities, causing significant impairment in daily life.) and anxiety disorder (disorder involves persistent and excessive worry that interferes with daily activities).
A review of Resident 17's H&P, dated 9/7/22, indicated Resident 17 did not have the capacity to understand or make decisions.
A review of Resident 17's Physician's Order for November 2022 indicated the following physician orders:
a. Remeron tablet 15 mg, give half tablet (7.5 mg) PO QHS for depression, manifested by verbalization of sadness; depression manifested by poor appetite.
Monitor side effects of anti-depressant every shift: fatigue, headache, tremor, somnolence, dizziness, insomnia, agitation, palpitations/tachycardia, gastrointestinal, nausea and vomiting, diarrhea/constipation, anorexia, dry mouth/thirst, increased appetite, confusion/delirium-sodium level, pain, and skin rash.
A review of Resident 17's MAR for the month of November 2022, indicated Resident 17 had 0 signs and symptoms of side effects from anti-depressant, Remeron from 1/1/22 to 11/13/22.
A review of Resident 17's care plan for psychotropic drugs dated 9/12/22, indicated Resident 17 had the potential for drug related complications associated with the use of psychotropic medication to manage mood/behavior related to anxiety and insomnia. The care plan indicated interventions that included to observe for antidepressant side effects: such as orthostatic hypotension and tachycardia.
During an interview on 11/12/22 at 3:15 PM, LVN 3 stated licensed nurses would monitor residents who were taking psychotropic medications for any signs and symptoms of side effects. LVN 3 stated side effects monitoring would be reflected in the resident's eMAR as a number code.
During an interview on 11/13/22 at 1:32 PM, LVN 5 stated when residents admit to the facility, nurses would check and monitor resident's vital signs every shift for 72 hours, then weekly and would document in weekly summary and would log the vital signs on the resident's eMAR. LVN stated licensed nurses would monitor residents for psychotropic medications' side effects and would document 0 in eMAR if no side effects were observed. LVN 5 stated licensed nurses assessed residents for orthostatic hypotension by checking residents if they were not feeling good. LVN 5 stated if residents passed out, licensed nurses would check residents' BP. LVN 5vstated licensed nurse would monitor residents for tachycardia by monitoring residents for any signs of shortness of breath or palpitations. LVN 5 stated by not monitoring residents orthostatic BP or heart rate, licensed nurses were not accurately monitoring residents' psychotropic medications side effects as ordered.
During an interview on 11/13/22 at 4:32 PM, the Director of Nursing (DON) stated residents on psychotropic medications should be monitored every shift. The DON stated residents on psychotropic medications could experience side effects like dizziness, difficulty of walking, tachycardia, etcetera. The DON stated residents taking psychotropic medications could also experience orthostatic hypotension, thus checking BP while sitting, standing, and lying were important. The DON stated if licensed nurses were not checking residents heart rate or BP then the assessment for signs of psychotropic side effects were not accurate.
A review of facility's policy and procedure (P&P) titled, Antipsychotic Medication Use, revised in 12/2016, indicated nursing staff shall monitor for and report any of the following side effects and adverse consequences of antipsychotic medications to the attending physician such as orthostatic hypotension or arrhythmias (irregular heartbeat).
3. A review of Resident 21's admission Record indicated the resident was initially admitted to the facility on [DATE] with diagnoses that included anxiety disorder (a mental health disorder characterized by feelings of worry, anxiety, or fear that are strong enough to interfere with one's daily activities) and major depressive disorder (a mood disorder that interferes with daily life).
A review of Resident 21's History and Physical (H&P), dated 10/1/21, indicated Resident 21 could make needs known but could not make medical decisions.
A review of Resident 21's Minimum Data Set (MDS, a standardized resident assessment and care-screening tool), MDS, dated [DATE], indicated the resident required extensive assistance from staff for transferring, dressing, toileting, and personal hygiene.
A review of Resident 21's Physician's Order for November 2022 indicated the following physician orders:
a. Remeron [Mirtazapine, antidepressant/drug that treats depression (mental disorder characterized by persistently depressed mood or loss of interest in activities)] tablet 15 mg, to give 1 tablet by mouth (PO) at bedtime (QHS) for depression, manifested by self-reporting feeling of sadness, dated 5/12/22.
b. Monitor side effects of anti-depressant every shift: fatigue, headache, tremor, somnolence (drowsiness), dizziness, insomnia (inability to sleep), agitation (anxiety), palpitations/tachycardia (fast heart rate), gastrointestinal (GI, relating to the stomach and the intestines), nausea and vomiting, diarrhea/constipation, anorexia (lack or loss of appetite for food), dry mouth/thirst, increased appetite, confusion/delirium-sodium (nutrient) level, pain, and skin rash.
A review of Resident 21's Medication Administration Record (MAR) for the month of November 2022, indicated Resident 1 had 0 signs and symptoms of side effects from anti-depressant, Remeron from 11/1/22 to 11/12/22.
A review of Resident 21's care plan for psychotropic drugs dated 7/6/22, indicated Resident 21 had the potential for drug related complications associated with the use of psychotropic medication to manage mood/behavior related to depression, anxiety, and impulse disorder (condition in which a person has trouble controlling emotions or behavior). The care plan indicated the interventions that included to observe for antidepressant side effects: such as orthostatic hypotension and tachycardia.
A review of Resident 21's Vital Stats from 11/1/22 to 11/13/22, indicated Resident 21's vital signs (group of medical signs that indicate the status of the body's vital functions) such as temperature, PR, respiratory (breathing) rate and BP were taken and recorded/ documented on 11/1/22 and 11/8/22.
4. A review of Resident 25's admission Record indicated the resident initially admitted to the facility on [DATE] with diagnoses that included major depressive disorder, mild cognitive (thinking and reasoning) impairment, and essential hypertension.
A review of Resident 25's MDS, dated [DATE], indicated the resident required extensive assistance from staff for transferring, dressing, toileting use, and personal hygiene.
A review of Resident 25's Physician's Order for November 2022 indicated the following physician orders:
a. Remeron 15 mg, to give 1 tablet PO QHS for depression, manifested by poor appetite eating less than 50% of meals, dated 3/17/22.
b. Monitor side effects of anti-depressant every shift for palpitations/tachycardia.
A review of Resident 25's MAR for the month of November 2022 indicated, Resident 25 had 0 signs and symptoms of side effects from anti-depressant, Remeron from 1/1/22 to 11/12/22.
A review of Resident 25's care plan for psychotropic drugs dated 11/9/22, indicated Resident 25 had the potential for drug related complications associated with the use of psychotropic medication to manage mood/behavior related to depression, anxiety, and impulse disorder. The care plan indicated interventions that included to observe for antidepressant side effects: such as orthostatic hypotension and tachycardia.
A review of Resident 25s Vital Stats for period 11/1/22 to 11/13/22 indicated Resident 25's vital signs such as temperature, PR, respiratory (breathing) rate and BP were only taken and recorded/documented on 11/6/2022 and 11/12/2022, and 11/13/2022 (total of 3 days for the month of November).
5. A review of Resident 26's admission Record indicated the resident initially admitted to the facility on [DATE] with diagnoses that included major depressive disorder, dementia and chronic obstructive pulmonary disease (COPD, group of lung diseases that block airflow and make it difficult to breathe).
A review of Resident 26's H&P, dated 5/6/2022, indicated Resident 26 has altered mental status (mental capacity) with significant cognitive dysfunction (impairment).
A review of Resident 26's MDS, dated [DATE], indicated the resident required extensive assistance from staff for dressing, personal hygiene.
A review of Resident 26's Physician's Order for November 2022 indicated the following physician orders:
a. Mirtazapine tablet 15 mg, to give 1 tablet PO QHS for depression manifested by poor appetite eating less than 50% meals, dated 5/6/22.
b. Monitor side effects of anti-depressant every shift for palpitations/tachycardia.
A review of Resident 26's MAR for the month of November 2022 indicated, Resident 26 had 0 signs and symptoms of side effects from anti-depressant, Remeron from 1/1/22 to 11/12/22.
A review of Resident 26's care plan for psychotropic drugs dated 9/22/22, indicated Resident 26 had the potential for drug related complications associated with the use of psychotropic medication to manage mood/behavior related to depression, anxiety, and impulse disorder. The care plan indicated interventions that included to observe for antidepressant side effects: such as orthostatic hypotension and tachycardia.
A review of Resident 26's Vital Stats for period 11/1/22 to 11/13/22, indicated Resident 26's vital signs were only taken and recorded/documented on 11/2/22 and 11/9/22.
6. A review of Resident 30's admission Record indicated the resident was initially admitted to the facility on [DATE] and re-admitted on [DATE] with diagnoses that included muscle weakness, spinal stenosis (occurs when one or more bony openings within the spine begin to narrow and reduce space for the nerves) and osteoarthritis (occurs when flexible tissue at the ends of bones wears down).
A review of Resident 30's H&P, dated 6/18/22, indicated Resident 30 did not have the capacity to understand or make decisions.
A review of Resident 30's MDS, dated [DATE], indicated Resident 30 required extensive assistance with bed mobility, transfer, dressing, eating, toilet use, and personal hygiene.
A review of Resident 30's Physician's Order for November 2022 indicated the following physician orders:
a. Zyprexa (Olanzapine-antipsychotic/used to treat psychotic conditions) tablet 2.5 mg, to give 1 tablet PO QHS for psychosis manifested by striking out during nursing care dated 9/12/22.
b. Monitor side effects of anti-psychotic every shift for orthostatic hypotension.
A review of Resident 30's MAR for the month of November 2022 indicated, Resident 30 had 0 signs and symptoms of side effects from anti-psychotic, Zyprexa from 11/1/22 to 11/12/22.
A review of Resident 30's care plan for psychotropic drugs dated 10/3/22, indicated Resident 30 had the potential for drug related complications associated with the use of psychotropic medication to manage mood/behavior related to psychosis. The care plan indicated interventions that included to observe for antidepressant side effects: such as orthostatic hypotension and tachycardia.
A review of Resident 30's Vital Stats for period 11/1/22 to 11/13/22 indicated Resident 30's vital signs were only taken and recorded/documented on 11/6/22 and 11/13/22.
On 11/12/22 at 4:21 PM, during an interview with a Licensed Vocational Nurse 6 (LVN 6) and review of Resident 30's electronic MAR (eMAR), LVN stated licensed nurses were monitoring Resident 30 and other residents who are taking psychotropic medications for side effects every shift. LVN 6 stated licensed nurses would document the corresponding number/code for whatever side effects the residents were experiencing. LVN stated Resident 30, licensed nurses were monitoring Resident 30 for anti-psychotic side effects every shift and would document 0 if no side effects identified/observed and/or would document number 1 for sedation, 2 for drowsiness, etcetera.
7. A review of Resident 62's admission Record indicated the resident was initially admitted to the facility on [DATE] with diagnoses that included dementia, muscle weakness, syncope (fainting) and collapse.
A review of Resident 62's H&P, dated 10/19/2022, indicated Resident 62 did not have the capacity to understand and make decisions.
A review of Resident 62's MDS, dated [DATE], indicated Resident 62 required limited assistance from staff for bed mobility, transferring, dressing, eating, toileting, and personal hygiene.
A review of Resident 62's Physician's Order for November 2022 indicated the following physician orders:
a. Mirtazapine tablet 7.5 mg, to give 1 tablet PO QPM for depression manifested by poor appetite eating less than 50% meals, dated 1/6/22.
b. Monitor side effects of anti-depressant every shift for palpitations/tachycardia.
A review of Resident 62's MAR for the month of November 2022 indicated, Resident 62 had 0 signs and symptoms of side effects from anti-depressant, Remeron from 11/1/22 to 11/12/22.
A review of Resident 62's care plan for psychotropic drugs dated 11/11/22, indicated Resident 62 had the potential for drug related complications associated with the use of psychotropic medication to manage mood/behavior related to depression, anxiety, and impulse disorder. The care plan indicated interventions that included to observe for antidepressant side effects: such as orthostatic hypotension and tachycardia.
A review of Resident 62's Vital Stats for period 11/1/22 to 11/13/22 indicated Resident 62's vital signs were only taken and recorded/documented on 11/4/22, 11/9/22, and 11/11/22.
Based on interview, and record review, the facility failed to provide adequate pharmacy services for nine (9) of 9 sampled Residents.
1. Resident 78's medication was not accounted for when the medication was brought into the facility.
2. Resident 3's anticoagulant (medication used to prevent blood clots) medication was not monitored for side effects
3. Residents 21, 25, 26, 30, 62, 13, and 17, heart rate (HR, the number of times each minute that the heart beats) and blood pressure (BP, pressure inside the blood vessels) were not being checked and documented every shift (7 AM to 3 PM, 3 PM to 11 PM, 11 PM to 7 AM) to identify signs of psychotropic side effects such as tachycardia (rapid heartbeat, HR over 100 beats a minute) and orthostatic hypotension (form of low blood pressure that happens when standing up from sitting or lying down).
These deficient practices had the potential for the residents to experience unidentified side effects which could lead to serious health complications requiring hospitalization or death.
Findings:
1. A review of Resident 78's admission Record indicated the resident admitted to the facility on [DATE] with diagnoses of hypertension (HTN, high blood pressure), gout (a type of arthritis [inflammation or swelling of one or more joints] that occurs when extra uric acid in the body forms crystals in the joints), and dementia (impaired ability to remember, think, or make decisions that interferes with doing everyday activities).
A review of Resident 78's History and Physical, dated 6/9/22, indicated the resident did not have capacity to understand or make decisions.
A review of Resident 78's Minimum Data Set (MDS, standardized assessment and care-screening tool), dated 9/14/22, indicated the resident required extensive assistance (staff provide weight bearing support) from staff for transferring, dressing, eating, toileting, and personal hygiene.
A review of Resident 78's Physician's Orders, dated 6/10/22, indicated an order for Losartan Potassium (a medication used to treat high blood pressure) 100 milligram (mg, a unit of measurement) take 1 tab by mouth (PO) once daily (QDay) for HTN.
A review of Resident 78's Physician's Orders, dated 6/10/22, indicated an order for Allopurinol (a medication used to treat gout) 100 mg tablet, take 1 tab PO QDay for gout.
A review of Resident 78's monthly Medication Administration Record (MAR) for June, August, September, and October 2022, indicated the licensed nurses documented that Losartan and Allopurinol were administered as ordered at 9 am.
A review of Resident 78's monthly MAR for July 2022, indicated Allopurinol and Losartan were not administered because the resident refused on 7/9/22. The July 2022 MAR indicated the licensed nurses documented that Losartan and Allopurinol were administered all the other days as ordered at 9 am.
A review of Resident 78's monthly MAR for November 2022, indicated dated 11/1/22 to 11/12/22 indicated the licensed nurses documented that Losartan and Allopurinol were administered as ordered at 9 am from 11/1/22 to 11/12/22.
During an observation and interview with a Licensed Vocational Nurse 1 (LVN 1) of Medication Cart 1 in [NAME] Station II on 11/12/22 at 7:40 AM, the following medications were observed in a clear orange medication bottle for Resident 78:
a. Allopurinol (used to treat gout and certain types of kidney stones) 100 milligrams (mg, a unit of measurement) tablet, take 1 tablet every day as directed. 22 tablets left in the bottle.
b. Losartan (used to treat high blood pressure hypertension and to help protect the kidneys from damage due to diabetes) 100 mg tablet, take 1 tablet every day as directed. 23 tablets left in the bottle.
Allopurinol indicated a fill date on 5/28/22 with a quantity of 90 tablets. Losartan indicated a fill date of 5/28/22 with a quantity of 90 tablets. Both medications were observed with black writing on the bottle indicating date opened (D.O.) on 6/10/22.
LVN 1 stated if both medications (Allopurinol and Losartan) were filled on 5/28/22 and dated opened on 6/10/22, the medications should all be completed (none left in the bottle). LVN 1 stated she did not know why there were tablets (Losartan and Allopurinol) remaining. LVN 1 stated the Resident 78's Responsible Party (RP) might have brought the extra medications to the facility. LVN 1 stated she would not count the contents of the medications if it was not from the facility's pharmacy if the medication bottle was opened. LVN 1 stated the date opened indicated the first dose given from that medication bottle.
During an observation and interview, on 11/12/22 at 4:39 PM, Resident 78's RP was pushing the resident in a wheelchair in the facility. RP stated she brought in Resident 78's medications for the licensed nurses to administer to Resident 78. RP stated she did not know if Resident 78 was refusing medications and/or if medications were not administered. RP stated the facility staff did not notify her if doses were missed.
During an interview, on 11/13/22 at 7:50 AM, LVN 5 stated medication reconciliation was performed by the night (11 pm to 7 am) shift and was important to perform as to reflect each resident's current and most updated order from the physician. LVN 5 stated all licensed nurses were responsible to check all medications the resident and/or family brought into the facility. LVN 5 stated licensed nurses were responsible for ensuring that the resident had a physician's order. LVN 5 stated it was typical for residents or resident's family to bring in outside medication, but the facility was responsible for checking all medications and the contents of the medication and ensuring the resident had a physician's order for outside medications to be administered. LVN 5 stated licensed nurses must count the quantity of all resident's medications when receiving outside, sealed/unsealed medications, and must verify the medications with another licensed nurse. LVN 5 stated the medication was then logged into a binder titled, Outside Pharmacy and Family Log, to account for the resident's medication. LVN 5 stated each nurse's station had their own specific binder. LVN 5 stated if it was not logged on the binder, licensed nurses would be unable to track and account for resident's medications that the family brought into the facility.
During an interview, on 11/13/22 at 10:05 AM, the Director of Nursing (DON) stated when family brings medications into the facility for residents, licensed nurses were expected to check the prescription and compare it to the physician's order. Once confirmed appropriate order, the medication was then logged into the binder titled, Outside Pharmacy and Family Log, for the nurse's station the resident resided in. The DON stated whoever received the medication was responsible to log the medication in the binder. The DON stated when medication bottles were unsealed, the licensed nurse must count the contents of the medication in the bottle with another licensed nurse for verification. The DON could not provide documentation Resident 78's Allopurinol and Losartan were counted initially and/or explain why there were remaining medications (if it was opened on 6/10/22).
A review of [NAME] I Station's Outside Pharmacy and Family Log, on 11/12/22 at 8:12 AM, LVN 5 stated the log did not indicate Resident 78 received any medications.
A review of [NAME] II Station's Outside Pharmacy and Family Log,on 11/13/22 at 9:22 AM, LVN 4 stated the log did not indicate Resident 78 received any medications.
A review of [NAME] Station's Outside Pharmacy and Family Log, on 11/13/22 at 2:15 PM, LVN 3 stated the log did not indicate Resident 78 received any medications.
A review of the facility's policy and procedure (P&P) titled, Administering Medications, revised 4/19, indicated medications were administered in a safe and timely manner, and as prescribed.
A review of the facility P&P titled, Medication Storage in the Facility, dated 4/08, indicated medications and biologicals were stored safely, securely, and properly following manufacturer's recommendations of those of the supplies. The P&P indicated the transfer of medications from one container to another was done only by pharmacy.
A review of the facility's P&P titled, Reconciliation of Medications on Admission, revised 7/17, indicated to ensure medication safety by accurately accounting residents' medications, routes, and dosages upon admission or readmission to the facility. The P&P indicated medication reconciliation reduced medication errors and enhanced resident safety by ensuring that the medications the resident needed and had been taking continued to be administered without interruption.
A review of the facility's P&P titled, Medications Brought to the Facility by a Resident or Family Member, dated 9/14, indicated medication brought into the facility by a resident or family member was used only upon written order by the resident's attending physician, after the contents were verified, and if the packaging met the facility's guidelines. The P&P indicated licensed nurses received medications delivered to the facility and documented delivery of the medication on the appropriate form.
2. A review of Resident 3's Face Sheet (a record of admission) indicated the resident admitted to the facility on [DATE] with diagnoses that included atrial fibrillation [A Fib, an irregular and often very rapid heart rhythm (arrhythmia) that can lead to blood clots in the heart], presence of a cardiac pacemaker [a small device that's placed (implanted) in the chest to help control the heartbeat], and heart failure (heart's inability to pump an adequate supply of blood to the body).
A review of Resident 3's Minimum Data Set (MDS, a standardized assessment and care-screening tool), dated 9/30/22, indicated the resident no impairment in cognitive skills (ability to make daily decisions).
A review of Resident 3's monthly Physician Orders for November 2022, indicated the following orders for the resident:
a. Eliquis (Apixaban, a medication used to prevent serious blood clots from forming due to a certain irregular heartbeat) 2.5 mg tablet by mouth (PO) two times a day (BID) for A Fib.
b. Monitor for any signs and symptoms of bleeding related to Xarelto (Rivaroxaban, a medication used to prevent blood clots from forming due to a certain irregular heartbeat every shift for A Fib).
The Physician orders did not indicate an order to monitor for any signs and symptoms of bleeding for Eliquis, nor did the Physician orders indicate an order for Xarelto.
A review of Resident 3's care plan titled, Risk for complications from use of blood thinning medication related to A-Fib, dated 7/20/22, indicated the resident was receiving Eliquis 2.5 mg one (1) tablet PO BID for A-Fib and did not have Xarelto.
During an observation in Resident 3'sroom and interview on 11/11/22 at 10 AM, Resident 3 had discoloration to her hands and face. Resident 3 stated she always had some discoloration to her hands and face due to a history of skin cancer. Resident 3 stated she had a stroke and was on medications to prevent blood clots.
During an interview and record review of Resident 3's Physician Orders on 11/13/22 at 7:50 AM, Licensed Vocational Nurse 5 (LVN 5) stated medication reconciliation was performed by the night shift (11 PM to 7 AM) licensed nurses, in which the resident's medications were reviewed according to the physician's orders and updated to ensure accuracy. LVN 5 stated that Resident 3's anticoagulant medication, Eliquis, did not match the physician's order for monitoring bleeding related to the medication Xarelto. LVN 5 stated that Eliquis and Xarelto were different anticoagulant medications. LVN 5 stated she could not recall if Resident 3 was ever on Xarelto.
During an interview on 11/13/22 at 9:58 AM, the Director of Nursing (DON) stated it was important to monitor for bleeding because there was a risk for bleeding while the resident was on Eliquis. The DON stated Resident 3's physician order and Medication Administration Record (MAR) indicated Resident 3 was on Eliquis, but licensed nurses were monitoring for bleeding for the use of Xarelto. The DON stated accuracy of resident's records was important to ensure safety and to avoid confusion.
A review of the facility's policy and procedure titled, Anticoagulant- Clinical Protocol, revised 11/18, indicated nurses shall assess and document current anticoagulation therapy, including drug and current dosage.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Medication Errors
(Tag F0758)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview, and record review, the facility failed to ensure PRN (given as needed and not on a regular schedule) order f...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on interview, and record review, the facility failed to ensure PRN (given as needed and not on a regular schedule) order for Ativan (psychotropic medication [medication which affects brain activities associated with mental processes and behaviors] used to treat anxiety [fear characterized by behavioral disturbances]) was not extended beyond 14 days without a documented rationale for extended use for one out of five residents (Resident 21) in accordance with the facility policy and procedure.
This deficient practice increased the risk for Resident 21 to experience adverse effects of psychotropic medication therapy including, but not limited to, dizziness, drowsiness, leading to an overall negative impact on her physical, mental, and psychosocial well-being.
Findings:
A review of Resident 21's admission record indicated the resident was initially admitted to the facility on [DATE] with diagnoses that included dementia (a group of thinking and social symptoms that interferes with daily functioning), anxiety disorder and major depressive disorder (a mood disorder that interferes with daily life).
A review of Resident 21's History and Physical (H&P), dated 10/1/2021, indicated Resident 21 can make needs known but cannot make medical decisions.
A review of Resident 21's Minimum Data Set (MDS, a standardized resident assessment and care-screening tool), dated 9/19/2022, indicated Resident 21 required extensive assistance (resident involved in activity; staff provide weight-bearing support) with bed mobility, transfer, dressing, toilet use, personal hygiene and required limited assistance (resident highly involved in activity; staff provide guided maneuvering of limbs or other non-weight bearing assistance) with eating.
A review of Resident 21's Physician's Order for November 2022 indicated the physician order of Ativan (Lorazepam) tablet 0.5 milligrams (mg- a unit of measurement), to give 1 tablet by mouth every 24 hours as needed for anxiety manifested by hitting staff dated 7/2/2022 and with end date of 7/26/2022.
A review of Resident 21's Physician's Progress Notes dated 7/17/2022, indicated, Resident 21's attending physician (AP) 1 documented to keep the Ativan 0.5 mg every 24 hours as needed due to Resident 21's severe aggression for 30 days.
A review of Resident 21's Medication Administration Record (MAR) for the month of November 2022, indicated to give Ativan 0.5 mg tablet every 24 hours as needed for anxiety with a start date of 7/26/2022 and end date of N/A (not applicable).
On 11/12/22 at 3:15 PM, during interview, Licensed Vocational Nurse 3 (LVN 3) stated he was not sure why the AP 1 ordered Ativan PRN for 30 days instead of 14 days.
On 11/12/22 at 3:34 PM, during a concurrent interview with LVN 5 and review of Resident 21's Physician's order for the month of November 2022, LVN 5 stated Ativan 0.5 mg PRN was initially ordered on 7/2/22 and was re-ordered on 7/26/22. LVN 5 stated there were no documented rationale for Ativan 0.5 mg PRN when it was reordered on 7/26/22. LVN 5 stated she reminded the AP 1 that the facility's protocol for PRN psychotropic medication was limited to only 14 days due to risk of adverse effects, but the AP 1 likes to order PRN Ativan psychotropic medication for 30 days. LVN 5 stated AP 1 must renew the Ativan 0.5 mg PRN with documented rationale every 30 days.
During an interview on 11/13/22 at 10:19 AM, the Director of Nursing (DON) stated PRN psychotropic medication can be extended beyond 14 days if residents were using it very often. The DON stated the doctor does not want to be bothered in renewing the medication very often. The DON stated the doctors were aware that PRN psychotropic should be limited to 14 days, but some doctors do not listen and wanted it for 30 days. The DON stated PRN psychotropic medication can be ordered for more than 14 days if there were proper rationale and/or indication form the doctor.
A review of facility's policy and procedure titled Antipsychotic Medication Use revised in December 2016, indicated the following:
1. The need to continue PRN orders for psychotropic medications beyond 14 days requires that the practitioner document the rationale for the extended order. The duration of the PRN order will be indicated in the order.
2. The need to continue PRN orders for psychotropic medications beyond 14 days unless the healthcare practitioner has evaluated the resident for the appropriateness of that medication/
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0761
(Tag F0761)
Could have caused harm · This affected 1 resident
Based on observation, interview, and record review, the facility failed ensure the safe storage of medications by labeling when medications were opened. During an inspection of one of three medication...
Read full inspector narrative →
Based on observation, interview, and record review, the facility failed ensure the safe storage of medications by labeling when medications were opened. During an inspection of one of three medication carts (Medication Cart 2), two opened bottles of vitamins were not labeled when it was opened.
This deficient practice had the potential for the residents to take medications past recommended use after opening.
Findings:
During an inspection of Medication Cart 2 and interview with a Licensed Vocational Nurse 1 (LVN 1), on 11/12/22 at 8:03 AM, the following medications were opened and not labeled with an open date:
1. One bottle of Vitamin D (nutritional supplement) 25 microgram (mcg, unit of measurement) 100 tablets.
2. One bottle of Rosuvastatin Calcium (Crestor, used to treat high blood cholesterol).
LVN 1 stated the medications should be labeled when it was opened. LVN 1 stated the licensed nurses were responsible for checking all medications were properly labeled and stored to ensure residents did not receive expired medications. LVN 1 stated if used after expiration or the use by date, there was a chance it (the medications) might not work as intended and could cause harm to the resident.
A review of facility's policy and procedures (P&P) titled, Administering Medications, revised in April 2019, indicated the expiration/beyond use date on the medication label was checked prior to administering. When opening a multi-dose container, the date opened was recorded on the container.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0806
(Tag F0806)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview, and record review, the facility failed to address food preferences and/or provide an alternativ...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview, and record review, the facility failed to address food preferences and/or provide an alternative food menu for one of three sampled residents (Resident 187).
This deficient practice had the potential for the resident to not meet their nutritional needs.
Findings:
A review of Resident 187's admission Record indicated the resident admitted to the facility on [DATE] with diagnoses including essential hypertension (high blood pressure that does not have a known secondary cause), history of fall, and convulsions (rapid, involuntary muscle contractions that cause uncontrollable shaking and limb movement).
A review of Resident 187's Physician Orders for the month of November 2022, indicated a physician order for the resident to have a regular, consistent carbohydrate (eating the same amount of carbohydrates every day to help keep blood sugar levels stable) diet, three times a day.
A review of Resident 187's care plan for nutrition dated 11/4/22, indicated Resident 187 had nutritional concerns related to his condition such as HTN, diabetes mellitus (a condition that affects the way the body processes blood sugar), and chronic kidney disease (gradual loss of kidney function affecting the body's ability to filter waste and excess fluid from the blood) with interventions that included to assess likes and dislikes, honor dietary preferences. and offer alternative meals when available if the resident did not like what was served.
A review of Resident 187's Food Preference Record dated 11/4/22, indicated the resident's breakfast preference were to have oatmeal, toast, scrambled eggs, bacon, coffee, and water. It also indicated the resident normally only ate oatmeal at home.
During an interview on 11/11/22 at 8:42 AM, Resident 187 stated he was admitted to the facility a week ago (11/4/22) and had concerns about his food. Resident 187 stated he never got breakfast he wanted. Resident 187 stated one day (on 11/11/22) the facility served him scrambled egg, bacon, one sausage, and a toast. Resident 187 stated he preferred one egg over easy and a toast. Resident 187 stated when he first came in the facility, no one asked him what he liked, disliked, or if he had any breakfast preferences. Resident 187 stated there was another incident the facility served breakfast he did not like and because he waited for almost an hour he did not want to ask any more for an alternative.
During the same interview on 11/11/22 at 8:42 AM, inside Resident 187's room, Certified Nurse Assistant 1 (CNA 1) gave Resident 187 lunch menu for that day (11/11/22). Resident 187 informed CNA 1 about his problem with breakfast. CNA 1 told Resident 187 that the facility did not provide a breakfast menu since they served almost the same breakfast all the time. Resident 187 stated he did not want the same food for breakfast every day. CNA 1 informed Resident 187 to let the kitchen staff or the nurses know about his request. Resident 187 told CNA 1 that he went one time to the kitchen and was informed by the kitchen staff that he cannot request when the food was not there yet. Resident 187 stated he does not know what the best time is to tell the kitchen staff about his food request. CNA 1 told Resident 187 that she will ask someone from the kitchen to talk to him that day to ask for his food preference, especially food menu. Resident 187 stated he does not have a problem with the facility's food quality but more on miscommunication.
On 11/12/22 at 9:07 AM, during a concurrent interview with Resident 187 and review of Resident 187's meal ticket dated 12/12/22, indicated Resident 187's breakfast preferences to have two strips of bacon, black coffee, scrambled egg, oatmeal, toast, and water, no ice. Resident 187 stated he already told them that he wanted/liked coffee, milk, tomato juice, eggs over easy, cornflakes or cheerios, and toast. Resident 187 stated the kitchen staff indicated foods he did not want or liked. Resident 187 also stated no one came to talk to him or explained why the kitchen was not able to provide the food he requested.
During an interview on 11/12/22 at 9:12 AM, Licensed Vocational Nurse 1 (LVN 1) stated if residents wanted something else from the menu, residents could request for an alternative by letting the staff in the dining room know or let the nurse know.
During an interview on 11/12/22 at 10:23 AM, the Registered Dietitian (RD) stated upon admission RD would speak with newly admitted residents and ask for their allergies, likes, dislikes and food preferences. RD stated the facility had an alternative menu and residents could request for food not on the regular menu. RD stated if for any reason the facility was not able to accommodate resident's request, they would explain it to the resident or would call the resident's family if they could set something up. RD stated menu were posted in each station and residents would be given a check off menu before lunch and dinner. RD stated, unfortunately they did not have a menu for breakfast, but most breakfast items were available. RD stated residents could go to the kitchen as well and let the kitchen staff know if residents preferred something else. RD stated she spoke with Resident 187 during admission but Resident 187's breakfast preferences changed on a daily basis. RD stated she could update resident's preference in the system daily.
During an interview on 11/13/22 at 3:41 PM, the Director of Nursing (DON) stated the dietitian would talk to the residents about food preferences upon admission. The DON stated the facility could accommodate residents' food preferences and the facility provided alternative menus. If the residents' preferences changed, the resident could tell the nurses then they would notify the kitchen staff. The DON stated RD would update resident's preferences if it changed.
A review of facility's policy and procedure (P&P) titled, Resident Food Preferences, revised in 7/2017, indicated individual food preferences would be assessed and communicated to the interdisciplinary team (IDT, team of healthcare professionals from different professional disciplines). The P&P indicated the food services department would offer a variety of foods at each scheduled meal, as well as access nourishing snacks throughout the day and night.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Food Safety
(Tag F0812)
Could have caused harm · This affected 1 resident
Based on observation, interview, and record review, the facility failed to store food properly to prevent growth of microorganisms that could cause food borne illness.
This deficient practice had the...
Read full inspector narrative →
Based on observation, interview, and record review, the facility failed to store food properly to prevent growth of microorganisms that could cause food borne illness.
This deficient practice had the potential to result in foodborne illness.
Findings:
During initial kitchen tour with the Director of Dining Services (DDS), on 11/11/22 timed at 8:45AM an oatmeal container was left opened in the dry food storage area. The DDS stated the oatmeal container should have been closed because leaving it open exposed the oatmeal to bacteria and the residents could get food poisoning.
A review of the facility's policy and procedure (P&P) titled, Food and Supply Storage, revised 1/2022, indicated all food, non-food items and supplies used in food preparation shall be stored in such a manner as to prevent contamination to maintain the safety and wholesomeness of the food for human consumption.
CONCERN
(D)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0813
(Tag F0813)
Could have caused harm · This affected 1 resident
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview and record review, facility failed to ensure personal food items and other food were properly st...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on observation, interview and record review, facility failed to ensure personal food items and other food were properly stored and labeled. The following items were observed inside Medication room [ROOM NUMBER]:
1. Dry food inside one clear Ziploc bag labeled with Resident 61's name but not labeled with date inside the medication room refrigerator.
2. One opened bottle, 48 ounce (oz-unit of measurement) of apple sauce, not labeled with open date, inside the medication room refrigerator.
3. One box of green tea and one packet of crackers were found inside the medication room drawer.
This deficient practice had the potential for the cross contamination of medications and spread of infection to other residents.
Findings:
During a medication storage observation with a Licensed Vocational Nurse 2 (LVN 2), on 11/12/22 at 2:31 PM, two refrigerators were found inside Medication room [ROOM NUMBER] (one small refrigerator for refrigerated medications and one tall white refrigerator for facility house supply items that needed to be refrigerated):
1. Inside the white tall refrigerator, one clear Ziploc bag with dry snacks, labeled with a resident's name (Resident 61),
2. Inside the white tall refrigerator, one opened bottle, 48 ounces (oz, a unit of measurement) of apple sauce not labeled with date opened.
3. One box of green tea and one packet of crackers, unlabeled with name and date also found inside the Medication room [ROOM NUMBER] drawer mixed with facility's urine specimen collection containers (sample taken for medical testing).
During the same observation and interview, on 11/12/22 at 2:32 PM, LVN 2 stated that the opened apple sauce should be labeled with date when it was first opened. LVN 2 stated personal foods like the box of green tea and crackers should not be stored inside the medication room for infection control issues. LVN 2 stated resident's snacks or food should not be inside the medication room and should be labeled with name and date when it was received.
During an interview on 11/12/22 at 2:53 PM, the Director of Nursing (DON) stated personal food could not be stored in the medication room refrigerator. The DON stated if family wanted to bring food, families could give it to the staff and store it in the refrigerator in the lunchroom designated for residents and families.
A review of facility's policy and procedure (P&P) titled, Resident Food Services, Use and Storage of Food Brought to residents from Outside, revised in 1/2021, indicated the following if the prepared food was not served immediately to the resident, the food must be stored in a container with a tight-fitting lid, clearly labeled with the resident's name and room number, the date the food was brought to the resident, and also the use-by-date. Food should be consumed or used within 72 hours or per storage policy. The P&P also indicated if the food was potentially hazardous, it must be stored either under refrigeration in the unit's pantry refrigerator or the resident's personal refrigerator (if available).
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Comprehensive Care Plan
(Tag F0656)
Could have caused harm · This affected multiple residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 10. A review of Resident 13's admission Record indicated the resident was admitted initially admitted to the facility on [DATE] ...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 10. A review of Resident 13's admission Record indicated the resident was admitted initially admitted to the facility on [DATE] and readmitted on [DATE] with a diagnosis that included hypertension (abnormally high blood pressure), hyperlipidemia (abnormally high concentration of fats or lipids in the blood), type 2 diabetes mellitus (a disease in which your blood glucose, or blood sugar, levels are too high).
A review of Resident 13's MDS, dated [DATE], indicated Resident 13's had severe impairment in cognitive skills.
A review of Resident 13's Physician's Order for November 2022 indicated the following physician orders:
a. Seroquel (Quetiapine, a drug treat schizophrenia, bipolar disorder, and depression) 25 milligram (mg, a unit of measurement) tablet, give half tablet (12.5 mg) PO every evening (QPM) for psychosis (mental disorder characterized by a disconnection from reality) manifested by delusions of calling mama and [NAME].
b. Monitor side effects antipsychotic such as: sedation, drowsiness/dizziness, dry mouth, constipation, blurred vision, extrapyramidal reaction, weight, seizures, urinary retention, tardive dyskinesia, cognitive/behavior impairment, akathisia, pseudo-Parkinsonism, orthostatic hypotension, unsteady on feet, and/or high blood sugar.
A review of Resident 13's care plan for psychotropic drugs dated 7/6/22, indicated Resident 13 had the potential for drug related complications associated with the use of psychotropic medication to manage behavior related to depression and psychosis. The care plan indicated the interventions that included to observe for antidepressant side effects: such as orthostatic hypotension and tachycardia.
11. A review of Resident 17's admission Record indicated the resident was admitted initially to the facility on 6/17/04 and readmitted on [DATE] with a diagnosis that included insomnia (a sleep disorder in which you have trouble falling and/or staying asleep) and anxiety disorder (disorder involves persistent and excessive worry that interferes with daily activities).
A review of Resident 17's H&P, dated 9/7/22, indicated Resident 17 did not have the capacity to understand or make decisions.
A review of Resident 17's Physician's Order for November 2022 indicated the following physician orders:
a. Remeron tablet 15 mg, give half tablet (7.5 mg) PO QHS for depression, manifested by verbalization of sadness; depression manifested by poor appetite.
Monitor side effects of anti-depressant every shift: fatigue, headache, tremor, somnolence, dizziness, insomnia, agitation, palpitations/tachycardia, gastrointestinal, nausea and vomiting, diarrhea/constipation, anorexia, dry mouth/thirst, increased appetite, confusion/delirium-sodium level, pain, and skin rash.
A review of Resident 17's care plan for psychotropic drugs dated 9/12/22, indicated Resident 17 had the potential for drug related complications associated with the use of psychotropic medication to manage mood/behavior related to anxiety and insomnia. The care plan indicated interventions that included to observe for antidepressant side effects: such as orthostatic hypotension and tachycardia.
During an interview on 11/13/22 at 1:13 PM, the Care Plan Coordinator (CPC) stated care plans were an indicator of a resident's overall status and wellbeing. The CPC stated care plans were used to make a resident's life better and ensure the quality of care for the resident. The CPC stated care plans were resident specific in which residents' concerns were identified and incorporated. The CPC stated that the care plans was generalized and not specific to each residents and did not have a specific deadline and was on going.
During an interview on 11/13/22 at 1:32 PM, LVN 5 stated when residents come in the facility for admission, nurses would check and monitor resident's vital signs every shift for 72 hours, then weekly and would document in the weekly summary and would log in vital sign documentation in the eMAR. LVN 5 stated licensed nurses would monitor residents for psychotropic medications' side effects and would document 0 in eMAR if no side effects were observed. LVN 5 stated licensed nurses assess residents for orthostatic hypotension side effects by checking residents if they were not feeling good and if the residents passed out, licensed nurses would check residents' BP. LVN 5 stated licensed nurse would monitor residents for tachycardia side effects by monitoring residents for any signs of shortness of breath and palpitations. LVN 5 stated by not monitoring residents orthostatic BP and pulse rate, licensed nurses were not accurately monitoring residents' psychotropic medications side effects as ordered.
During an interview on 11/13/22 at 4:30 PM, the Director of Nurses (DON) stated the care plan was utilized daily and was the plan of care for a resident in every aspect. The DON stated care plans must be resident-centered and resident specific indicated by a resident's specific medical condition. The DON stated the residents care plan must have a goal that was measurable and must be indicated by a specific time frame and objective. The DON stated that a resident's care plan must address the resident's specific problem, and that when care plans were not resident specific and indicated with a measurable goal the efficacy of the plan of care could not be determined or appropriately assessed. The DON stated care plan should not be generalized and should be specific to each resident.
A review of the facility policy and procedure titled, Care Plans, Comprehensive Person- Centered, revised 3/22, indicated a comprehensive person-centered care plan included measurable objectives and timetables to meet the resident's physical, psychosocial, and functional needs was developed and implemented for each resident. The policy indicated the comprehensive person- centered care plan included measurable objectives and timeframes.
3. A review of Resident 8's admission Record indicated the resident initially admitted to the facility on [DATE] with diagnoses including essential hypertension (HTN, high blood pressure that does not have a known secondary cause), dementia (a group of thinking and social symptoms that interferes with daily functioning), and urine retention (difficulty urinating and completely emptying the bladder).
A review of Resident 8's MDS, dated [DATE], indicated the resident had no impairment in cognitive skills (ability to make daily decisions) and required extensive assistance (resident involved in activity, staff provide weight-bearing support) from staff for bed mobility, transferring, dressing, toileting, and personal hygiene.
A review of Resident 8's Physician's Order for the month of November 2022 indicated the following physician orders:
a. Amlodipine Besylate [used treat high blood pressure (BP)] tablet, 5 milligrams (mg, a unit of measurement), to give 1 tablet by mouth (PO) every day (QDay).
b. Diltiazem CD (used treat high blood pressure) capsule, extended release 24 hour (slowly released into the body over a period of time, usually 24 hours), 360 mg, to give 1 capsule PO QDay.
c. Losartan 100 mg - hydrochlorothiazide [(HCTZ, medication used to treat water retention) a combination medication used to treat high blood pressure], 12.5 mg PO every evening (QPM).
A review of Resident 8's Medication Administration Record (MAR) for the month of November 2022, indicated Resident 8's blood pressure medications (Amlodipine, Diltiazem CD, and Losartan-HCTZ) were given every day as ordered without parameters when to not give the medications. The MAR indicated a BP check every week on Tuesday at nighttime. The MAR indicated the last BP check was done on 11/8/22.
A review of Resident 8's care plan for medical conditions dated 7/21/22, indicated Resident 8 had an alteration in cardiac (relating to the heart) status related to HTN with the following interventions:
a. Check and record heart rate, BP, and respirations (breathing). Inform the physician of readings outside of normal range.
b. Assess for cardiac distress, change in vital signs (group of medical signs that indicate the status of the body's vital functions, such as heart rate, BP, respiratory rate, and temperature), chest pain, dizziness, pallor (unhealthy pale appearance), apprehension (anxiety), and diaphoresis (excessive sweating).
c. Check BP every week on Tuesday.
During a medication administration observation and interview, on 11/12/22 at 8:42 AM, LVN 1 attempted to administer BP medications (Amlodipine, Diltiazem CD, and Losartan-HCTZ) and did not check the resident's BP because the resident did not have BP parameters (guideline/restriction) or an order to check BP prior to administration.
On 11/12/22 at 8:45 AM, during an interview and record review of Resident 8's eMAR, LVN 1 stated licensed nurse checked BP of residents who were taking BP medications once a week and would check vital signs once a week also for weekly summary. LVN 1 stated licensed nurses did not check residents BP unless there was a change in condition like unresponsiveness, dizziness or lightheadedness, or if ordered by the resident's physician. LVN 1 stated Resident 8 did not have any order for parameters any of the BP meds.
4. A review of Resident 187's admission Record indicated the resident admitted to the facility on [DATE] with diagnoses including essential HTN, history of fall, and convulsions (rapid, involuntary muscle contractions that cause uncontrollable shaking and limb movement).
A review of Resident 187's Physician's Order for the month of November 2022, indicated a physician order for Lisinopril (used to treat high blood pressure) tablet, 5 mg, to give 1 tablet PO QDay.
A review of Resident 187's MAR for the month of November 2022, indicated Resident 187's BP medication (Lisinopril) was given daily on 11/5/22 to 11/11/22 as ordered without BP parameters. There was no documentation on the MAR that BP was taken from 11/5/22 to 11/11/22.
A review of Resident 187's care plan for medical conditions dated 11/7/22, indicated Resident 187 had an alteration in cardiac status related to HTN with the following interventions:
a. Check and record heart rate, BP, and respirations. Inform the resident's physician for readings outside of normal range.
b. Assess for cardiac distress, change in vital signs, chest pain, dizziness, pallor, apprehension, and diaphoresis.
During a medication administration observation and interview with LVN 1 on 11/12/22 at 9:02 AM, LVN 1 observed attempted to administer Resident 187's BP medication (Lisinopril) and stated she did not check the resident's BP because the resident did not have BP parameters or an order to check BP prior to administration.
5. A review of Resident 21's admission Record indicated the resident was initially admitted to the facility on [DATE] with diagnoses that included anxiety disorder (a mental health disorder characterized by feelings of worry, anxiety, or fear that are strong enough to interfere with one's daily activities) and major depressive disorder (a mood disorder that interferes with daily life).
A review of Resident 21's History and Physical (H&P), dated 10/1/21, indicated Resident 21 could make needs known but could not make medical decisions.
A review of Resident 21's MDS, dated [DATE], indicated the resident required extensive assistance from staff for transferring, dressing, toileting, and personal hygiene.
A review of Resident 21's Physician's Order for November 2022 indicated the following physician orders:
a. Remeron [Mirtazapine, antidepressant/drug that treats depression (mental disorder characterized by persistently depressed mood or loss of interest in activities)] tablet 15 mg, to give 1 tablet PO at bedtime (QHS) for depression, manifested by self-reporting feeling of sadness, dated 5/12/22.
b. Monitor side effects of anti-depressant every shift for palpitations/tachycardia.
A review of Resident 21's care plan for psychotropic drugs dated 7/6/22, indicated the resident had the potential for drug related complications associated with the use of psychotropic medication to manage mood/behavior related to depression, anxiety, and impulse disorder (condition in which a person has trouble controlling emotions or behavior). The care plan indicated the following interventions:
a. Observe for antidepressant side effects: orthostatic hypotension (measuring BP while sitting and standing; BP and pulse are taken in two positions: supine and standing) and tachycardia. Notify the physician of noted side effects to determine if benefits of therapy outweigh side effects.
b. Observe for antipsychotic (medications used to treat psychotic disorders [severe mental disorders that cause abnormal thinking and perceptions]) side effects: orthostatic hypotension and tachycardia. Notify the physician of noted side effects to determine if benefits of therapy outweigh side effects.
6. A review of Resident 25's admission Record indicated the resident initially admitted to the facility on [DATE] with diagnoses that included major depressive disorder, mild cognitive (thinking and reasoning) impairment, and essential hypertension.
A review of Resident 25's MDS, dated [DATE], indicated the resident required extensive assistance from staff for transferring, dressing, toileting use, and personal hygiene.
A review of Resident 25's Physician's Order for November 2022 indicated the following physician orders:
a. Remeron 15 mg, to give 1 tablet PO QHS for depression, manifested by poor appetite eating less than 50% of meals, dated 3/17/22.
b. Monitor side effects of anti-depressant every shift for palpitations/tachycardia.
A review of Resident 25's care plan for psychotropic drugs dated 11/9/20/22, indicated the resident had the potential for drug related complications associated with the use of psychotropic medication to manage mood/behavior related to depression, anxiety, and impulse disorder. The care plan indicated the following interventions:
a. Observe for antidepressant side effects: orthostatic hypotension and tachycardia. Notify the physician of noted side effects to determine if benefits of therapy outweigh side effects
A review of Resident 25's Vital Stats for period 11/1/22 to 11/13/22 indicated Resident 21's vital signs BP was taken on 11/1/22 and 11/8/22 and vital signs were only taken and recorded/documented on 11/6/22 and 11/12/22, and 11/13/22. No documented evidence orthostatic BP were taken for the month of November 2022.
7. A review of Resident 26's admission Record indicated the resident initially admitted to the facility on [DATE] with diagnoses that included major depressive disorder, dementia and chronic obstructive pulmonary disease (COPD, group of lung diseases that block airflow and make it difficult to breathe).
A review of Resident 26's H&P, dated 5/6/2022, indicated Resident 26 has altered mental status (mental capacity) with significant cognitive dysfunction (impairment).
A review of Resident 26's MDS, dated [DATE], indicated the resident required extensive assistance from staff for dressing, personal hygiene.
A review of Resident 26's Physician's Order for November 2022 indicated the following physician orders:
a. Mirtazapine tablet 15 mg, to give 1 tablet PO QHS for depression manifested by poor appetite eating less than 50% meals, dated 5/6/22.
b. Monitor side effects of anti-depressant every shift for palpitations/tachycardia.
A review of Resident 26's care plan for psychotropic drugs dated 9/22/22, indicated the resident had the potential for drug related complications associated with the use of psychotropic medication to manage mood/behavior related to Depression, anxiety, and impulse disorder. The care plan indicated the following interventions:
a. Observe for antidepressant side effects: orthostatic hypotension and tachycardia. Notify the physician of noted side effects to determine if benefits of therapy outweigh side effects.
b. Observe for antipsychotic side effects: orthostatic hypotension and tachycardia. Notify the physician of noted side effects to determine if benefits of therapy outweigh side effects.
A review of Resident 26's Vital Stats for period 11/1/22 to 11/13/22, indicated Resident 26's vital signs were only taken and recorded/documented on 11/2/22 and 11/9/22. No documented evidence orthostatic BP were taken for the month of November 2022.
8. A review of Resident 30's admission Record indicated the resident was initially admitted to the facility on [DATE] and re-admitted on [DATE] with diagnoses that included muscle weakness, spinal stenosis (occurs when one or more bony openings within the spine begin to narrow and reduce space for the nerves) and osteoarthritis (occurs when flexible tissue at the ends of bones wears down).
A review of Resident 30's H&P, dated 6/18/22, indicated Resident 30 did not have the capacity to understand or make decisions.
A review of Resident 30's MDS, dated [DATE], indicated Resident 30 required extensive assistance with bed mobility, transfer, dressing, eating, toilet use, and personal hygiene.
A review of Resident 30's Physician's Order for November 2022 indicated the following physician orders:
a. Zyprexa (Olanzapine-antipsychotic/used to treat psychotic conditions) tablet 2.5 mg, to give 1 tablet PO QHS for psychosis manifested by striking out during nursing care dated 9/12/22.
b. Monitor side effects of anti-psychotic every shift for orthostatic hypotension.
A review of Resident 30's care plan for psychotropic drugs dated 10/3/22, indicated Resident 30 had the potential for drug related complications associated with the use of psychotropic medication to manage mood/behavior related to psychosis. The care plan indicated the following interventions:
a. Observe for antipsychotic side effects: orthostatic hypotension and tachycardia. Notify the physician of noted side effects to determine if benefits of therapy outweigh side effects.
A review of Resident 30's Vital Stats for period 11/1/22 to 11/13/22 indicated Resident 30's vital signs were only taken and recorded/documented on 11/6/22 and 11/13/22. No documented evidence orthostatic BP were taken for the month of November 2022.
9. A review of Resident 62's admission Record indicated the resident was initially admitted to the facility on [DATE] with diagnoses that included dementia, muscle weakness, syncope (fainting) and collapse.
A review of Resident 62's H&P, dated 10/19/2022, indicated Resident 62 did not have the capacity to understand and make decisions.
A review of Resident 62's MDS, dated [DATE], indicated Resident 62 required limited assistance from staff for bed mobility, transferring, dressing, eating, toileting, and personal hygiene.
A review of Resident 62's Physician's Order for November 2022 indicated the following physician orders:
a. Mirtazapine tablet 7.5 mg, to give 1 tablet PO QPM for depression manifested by poor appetite eating less than 50% meals, dated 1/6/22.
b. Monitor side effects of anti-depressant every shift for palpitations/tachycardia.
A review of Resident 62's MAR for the month of November 2022 indicated, Resident 62 had 0 signs and symptoms of side effects from anti-depressant, Remeron from 1/1/22 to 11/12/22.
A review of Resident 62's care plan for psychotropic drugs, dated 11/11/22, indicated Resident 62 had the potential for drug related complications associated with the use of psychotropic medication to manage mood/behavior related to depression, anxiety, and impulse disorder. The care plan indicated the following interventions:
a. Observe for antidepressant side effects orthostatic hypotension and tachycardia. Notify the physician of noted side effects to determine if benefits of therapy outweigh side effects.
A review of Resident 62's Vital Stats for period 11/1/22 to 11/13/22 indicated Resident 62's vital signs were only taken and recorded/documented on 11/4/22, 11/9/22, and 11/11/22. No documented evidence orthostatic BP were taken for the month of November 2022.
Based on interview and record review, the facility failed to implement resident-centered care plans with measurable outcomes for 11 of 11 sampled residents (Residents 14, 46, 8, 187, 21, 25, 26, 30, 62, 13, and 17).
This deficient practice generalized residents care with the inability to assess improvements and or declines in a resident health status.
Findings:
1. A review of Resident 14's admission Record indicated the resident admitted to the facility on [DATE] with diagnoses of hypertension (high blood pressure), urinary tract infection (UTI, infections that happen when bacteria, often from the skin or rectum, enter the urethra, and infect the urinary tract), and osteoporosis (a bone disease that occurs when the body loses too much bone, makes too little bone, or both).
A review of Resident 14's Minimum Data Set (MDS, a standardized assessment and care-screening tool), dated 11/2/22, indicated the resident did not have any impairment in cognitive skills (ability to make daily decisions) and required extensive assistance (staff provide weight bearing support) from staff for transferred, dressing, toilet use, and personal hygiene.
A review of Resident 14's care plan for Falls, initiated on 10/23/22, indicated the resident was found lying down next to her bed with head resting on a fabric. The care plan goal indicated will minimize risk of fall or injury
A review of Resident 14's care plan for cardiac, initiated 10/26/22, indicated Resident 14 had a diagnosis of hypertension and hyperlipidemia [high levels of fat particles (lipids) in the blood]. The care plan indicated the goal of, will minimize risk for cardiac distress.
2. A review of Resident 46's admission Record indicated the resident was admitted to the facility on [DATE] with diagnoses of hypertension, depression, and hypothyroidism (thyroid gland doesn't produce enough thyroid hormone).
A review of Resident 46's MDS, dated [DATE], indicated the resident had moderate impairment in cognitive skills and required limited assistance from staff for bed mobility, transferring, dressing, toileting, and personal hygiene.
A review of Resident 46's Care Plan for Hypothyroidism, dated 7/26/22, indicated the goal, will minimize complications of hypothyroidism of hyperthyroidism symptoms.
A review of Resident 46's Care Plan Osteoporosis, dated 7/26/22, indicated the goal, will minimize risk for spontaneous fracture and other complications from osteoporosis.
CONCERN
(E)
Potential for Harm - no one hurt, but risky conditions existed
Deficiency F0658
(Tag F0658)
Could have caused harm · This affected multiple residents
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 3. During a medication pass administration observation and interview, on 11/12/22 at 8:42 AM, LVN 1 attempted to administer BP m...
Read full inspector narrative →
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** 3. During a medication pass administration observation and interview, on 11/12/22 at 8:42 AM, LVN 1 attempted to administer BP medications (Amlodipine, Diltiazem CD, and Losartan-HCTZ) to Resident 8 and did not check the resident's BP. LVN 1 stated she did not check the resident's BP because the resident did not have an order for BP parameters (guideline/restriction) prior to administration.
On 11/12/22 at 8:45 AM, during an interview and record review of Resident 8's eMAR, LVN 1 stated licensed nurses checked BP of residents who were taking BP medications once a week and would check vital signs once a week also for weekly summary. LVN 1 stated licensed nurses did not check residents BP unless there was a change in condition like unresponsiveness, dizziness or lightheadedness, or if ordered by the resident's physician. LVN 1 stated Resident 8 did not have any order for parameters for any of the BP meds.
A review of Resident 8's admission Record indicated the resident initially admitted to the facility on [DATE] with diagnoses including essential HTN, dementia, and urine retention (difficulty urinating and completely emptying the bladder).
A review of Resident 8's MDS, dated [DATE], indicated the resident had no impairment in cognitive skills and required extensive assistance from staff for bed mobility, transferring, dressing, toileting, and personal hygiene.
A review of Resident 8's Physician's Order for the month of November 2022 indicated the following physician orders:
a. Amlodipine Besylate (used treat high BP) tablet, 5 mg to give 1 tablet PO every day (QD).
b. Diltiazem CD (used treat high blood pressure) capsule, extended release 24 hour (slowly released into the body over a period of time, usually 24 hours), 360 mg, to give 1 capsule PO QDay.
c. Losartan 100 mg - hydrochlorothiazide [(HCTZ, medication used to treat water retention) a combination medication used to treat high blood pressure], 12.5 mg PO every evening (QPM).
A review of Resident 8's MAR for the month of November 2022, indicated Resident 8's BP medications (Amlodipine, Diltiazem CD, and Losartan-HCTZ) were given everyday as ordered without BP parameters. The MAR indicated a BP check every week on Tuesday at nighttime. The MAR indicated a BP measurement taken on 11/8/2022.
A review of Resident 8's care plan for medical conditions dated 7/21/22, indicated Resident 8 had an alteration in cardiac (relating to the heart) status related to HTN with the following interventions:
a. Check and record heart rate, BP, and respirations (breathing). Inform the physician of readings outside of normal range.
b. Assess for cardiac distress, change in vital signs (group of medical signs that indicate the status of the body's vital functions, such as heart rate, BP, respiratory rate, and temperature), chest pain, dizziness, pallor (unhealthy pale appearance), apprehension (anxiety), and diaphoresis (excessive sweating).
c. Check BP every week on Tuesday.
A review of Resident 8's Vital Stats from 11/1/22 to 11/13/22, indicated a BP measurement and documentation done on 11/8/22 and 11/12/22.
4. During a medication pass administration observation and interview with LVN 1 on 11/12/22 at 9:02 AM, LVN 1 observed attempted to administer Resident 187's BP medication (Lisinopril) and stated she did not check the resident's BP because the resident did not have BP parameters or an order to check BP prior to administration.
A review of Resident 187's admission Record indicated the resident admitted to the facility on [DATE] with diagnoses including essential HTN, history of fall, and convulsions (rapid, involuntary muscle contractions that cause uncontrollable shaking and limb movement).
A review of Resident 187's Physician's Order for the month of November 2022, indicated a physician order for Lisinopril (used to treat high blood pressure) tablet, 5 mg to give 1 tablet PO QDay.
A review of Resident 187's MAR for the month of November 2022, indicated Resident 187's BP medication (Lisinopril) was given daily on 11/5/22 to 11/11/22 as ordered without BP parameters. There was no documentation on the MAR that BP was taken from 11/5/22 to 11/11/22.
A review of Resident 187's care plan for medical conditions dated 11/7/22, indicated Resident 187 had an alteration in cardiac status related to HTN with the following interventions:
a. Check and record heart rate, BP, and respirations. Inform the resident's physician for readings outside of normal range.
b. Assess for cardiac distress, change in vital signs, chest pain, dizziness, pallor, apprehension, and diaphoresis.
During an interview on 11/13/22 at 9:56 AM, the Director of Nursing (DON) stated not all residents who were on BP medications had BP parameters to monitor, and the parameters were dependent on certain physicians. The DON stated vital signs, including BPs were not checked daily. The DON stated BP measuring was only conducted with a change in condition or with signs and symptoms of hypertension/hypotension. The DON stated even if a resident was on BP medications, some residents did not have parameters, therefore BP measuring did not need to be performed. The DON stated BP measuring for some residents were done weekly. The DON stated BP monitoring should be done for any resident who was taking BP medications. The DON stated it had been an issue that she had brought up to the facility previously. The DON stated BP monitoring for any resident who was on BP medication was a basic nursing practice and that BP should be obtained daily and prior to administration of all BP medications.
A review of the facility policy and procedure titled, Administering Medications, revised 4/2019, indicated prior to administering medication the following information was checked/verified for each resident for vital signs, if necessary.
A review of the facility's policy and procedure titled, Blood Pressure, Measuring, revised 9/2010, indicated Hypertension was defined as blood pressure over 140/90 millimeters of mercury (mm/Hg) and should be reported to the physician. The policy indicated hypotension was defined as blood pressure less than 100/60 mm/Hg and should be reported to the physician. The policy indicated staff should record several readings throughout the day, including before and after meals.
Based on observation, interview, and record review the facility failed to ensure five of five sampled residents (Residents 49, 46, 14, 8, and 187) received appropriate care and services, according to current standards of practice. The facility did not check Residents 49, 46, 14, 8, and 187 blood pressures (BPs) prior to administration of BP medications.
This deficient practice had the potential for residents not to be monitored adequately for exacerbation in side effects of administered medications.
Findings:
1. During a medication pass observation and interview, on 11/12/22 at 8:21 AM, a Licensed Vocational Nurse 2 (LVN 2) prepared blood pressure (BP) medications to administer to Resident 49 and did not check the resident's BP. LVN 2 stated she did not check the resident's BP because the resident did not have an order for specific parameters for blood pressure medications.
A review of Resident 49's admission Record indicated the resident admitted to the facility on [DATE] with diagnoses of hypertension (HTN, high blood pressure), arthritis (inflammation or swelling of one or more joints), and dementia (a group of conditions characterized by impairment of at least two brain functions, such as memory loss and judgment).
A review of Resident 49's Minimum Data Set (MDS, standardized assessment and care planning tool), dated 10/13/22, indicated the resident had severe impairment in cognitive skills (ability to make daily decisions) required extensive assistance (resident involved with activity, staff provided weight-bearing support) from staff for dressing, toileting, and personal hygiene.
A review of Resident 49's Physician Orders, dated 4/2/21, indicated an order for lisinopril (treat high blood pressure and heart failure) 30 milligrams (mg, a unit of measurement) one (1) tablet (tab) by mouth (PO) daily (QD) for HTN.
A review of Resident 49's Physician Orders, dated 4/2/21, indicated an order for Isosorbide Mononitrate (effective in the short-term for decreasing systolic blood pressure, pulse pressure, and pulse wave reflection in patients with systolic hypertension) extended release (ER) 24 hour, 1 tab PO twice daily (BID) for HTN.
A review of Resident 49's Care Plan for Hypertension, dated 10/27/22, indicated an intervention to check and record heart rate, blood pressure and respirations and to inform the physician of readings outside of normal range. The Care Plan indicated to administer medications as ordered and to monitor for side effects. The care plan indicated to assess for cardiac distress such as change in vitals signs. The care plan indicated to check blood pressure every week on Sunday.
2. During a medication pass observation and interview on 11/12/22 at 8:32 AM, LVN 2 observed preparing Resident 46's BP medication and did not check the resident's BP prior to administration. LVN 2 stated she did not check the resident's BP because the resident did not have an order for BP parameters.
A review of Resident 46's admission Record indicated the resident was admitted to the facility on [DATE] with diagnoses of HTN, depression, and hypothyroidism (thyroid gland doesn't produce enough thyroid hormone).
A review of Resident 46's MDS, dated [DATE], indicated Resident 46 had moderate impairment in cognitive skills and required limited assistance from staff for transferring, dressing, toileting, and personal hygiene.
A review of Resident 46's Physician Orders, dated 12/3/21, indicated an order for Diltiazem (a medication used to treat high BP and chest pain) extended release (ER) 120 mg capsule, take 1 capsule PO QD for HTN.
A review of Resident 46's Care Plan for hypertension, dated 7/26/22, indicated the approach to check and record heart rate, blood pressure and respirations and to inform the physician of readings outside of normal range. The Care Plan indicated to administer medications as ordered and to monitor for side effects. The care plan indicated to check and log blood pressure every week on Sunday.
During a medication pass observation and interview on 11/12/22 at 8:44 AM, LVN 2 prepared to administer Resident 14's BP medication and did not check the resident's BP before administration. LVN 2 stated Resident 14 did not have an order for BP parameters so she did not have check it before administrating. LVN 2 stated residents BP were obtained weekly.
A review of Resident 14's admission Record indicated the resident admitted to the facility on [DATE] with diagnoses of hypertension, urinary tract infection (UTI, infections that happen when bacteria, often from the skin or rectum, enter the urethra, and infect the urinary tract), and osteoporosis (a bone disease that occurs when the body loses too much bone, makes too little bone, or both).
A review of Resident 14's MDS, dated [DATE], indicated the resident did not have any impairment in cognitive skills and required extensive assistance from staff for transferred, dressing, toilet use, and personal hygiene.
A review of Resident 14's Physician Orders, dated 10/27/22, indicated an order for Amlodipine (medication used to high blood pressure) 5 mg, take 1 tablet PO QD for HTN.
A review of Resident 14's Care Plan for hypertension, dated 10/26/22, indicated the approach to check and record heart rate, blood pressure and respirations and to inform the physician of readings outside of normal range. The Care Plan indicated to administer medications as ordered and to monitor for side effects. The care plan indicated to check blood pressure every week on Monday.
During an interview on 11/13/22 at 7:50 AM, LVN 5 stated residents who were on BP medication were initially monitored daily for BP prior to medication administration. LVN 5 stated once the BP was considered stabilized within the next three months, BP was then conducted once a week. LVN 5 stated if a residents BP was abnormal (not within range) then the resident's physician was notified. LVN 5 stated some residents' BP monitoring was ordered weekly and some were ordered monthly, depending on the residents' physicians. LVN 5 stated to counteract episodes of HTN or hypotension, BP monitoring should be conducted and measuring of the resident's BP was necessary to ensure appropriate range.